Sarah Gray is Tackle’s new National Support and Development Manager on a 3-year project funded by the National Lottery. The project is to support groups across England and work with healthcare professionals to set up new groups.
Hormone treatment might offer some protection from Covid-19, it’s reported. See more here And it can make PCa worse, this study finds. An online survey aiming to shed more light on the experience of PCa patients on this therapy is being conducted via this link And a London college has developed an online intervention to […]
Advanced PCa patients can take enzalutamide or abirerone at home instead of going into hospital for chemotherapy, NHS England says. It will relieve pressure on the NHS. The drugs are smarter, kinder treatments and could extend the lives of many more men, it’s said (May ’20). See more here: And a new treatment is being […]
A genetically modified virus that kills cancer cells and destroys their hiding places has been developed by British scientists. The dual-action virus targets both cancer cells and healthy cells which have been tricked into protecting the cancer from the immune system. The Oxford University study is the first time cancer-associated fibroblasts or CAFs within solid […]
A radical ‘seek and destroy’ treatment could extend the lives of thousands of men with advanced PCa. The approach is described by experts as ‘game changing’ (Jun ’19). See more at
The first signs of cancer can appear decades before diagnosis, scientists have found – a discovery that could revolutionise treatment (Feb ’20). See more here. And Public Health England has published a statistical bulletin on survival rates for many types of cancer based on recent data. It stressses the importance of early diagnosis. A […]
Prostate Cancer Foundation’s 2019 Patient Guide is said to be one of the best sources of information from diagnosis to survival of PCa. Download it for free here. Our New Research page is updated regularly.
The NHS confirmed that the chemotherapy drug docetaxel will be made available to prostate cancer patients as soon as they are diagnosed instead of having to wait until other treatments stop working. See. And NICE has approved a new drug, Darolutamide, as an option for treating hormone-relapsed PCa in men at high risk of developing […]